Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications

Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications Publisher Pubmed

Mohammadi E^{1, 2} ; Shafiee F³ ; Shahzamani K⁴ ; Ranjbar MM⁵ ; Alibakhshi A⁶ ; Ahangarzadeh S⁷ ; Beikmohammadi L⁸ ; Shariati L^{8, 9} ; Hooshmandi S¹¹ ; Ataei B⁷ ; Javanmard SH¹⁰

Source: Biomedicine and Pharmacotherapy Published:2021

Abstract

Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 virus strains has geographical diversity associated with diverse severity, mortality rate, and response to treatment that were characterized using phylogenetic network analysis of SARS-CoV-2 genomes. Although, there is no explicit and integrative explanation for these variations, the genetic arrangement, and stability of SARS-CoV-2 are basic contributing factors to its virulence and pathogenesis. Hence, understanding these features can be used to predict the future transmission dynamics of SARS-CoV-2 infection, drug development, and vaccine. In this review, we discuss the most recent findings on the mutations in the SARS-CoV-2, which provide valuable information on the genetic diversity of SARS-CoV-2, especially for DNA-based diagnosis, antivirals, and vaccine development for COVID-19. © 2021

Related Docs

View other Related Docs

1. Viewpoint: Origin of Sars-Cov-2, Viruses (2020)

2. Efficacy of Mrna, Adenoviral Vector, and Perfusion Protein Covid-19 Vaccines, Biomedicine and Pharmacotherapy (2022)

3. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (6)

Farshid Noorbakhsh (2)

Style	Citing Format
MLA	Mohammadi E, et al.. "Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications." Biomedicine and Pharmacotherapy, vol. 139, no. , 2021, pp. -.
APA	Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, Shariati L, Hooshmandi S, Ataei B, Javanmard SH (2021). Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications. Biomedicine and Pharmacotherapy, 139(), -.
Chicago	Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, et al.. "Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications." Biomedicine and Pharmacotherapy 139, no. (2021): -.
Harvard	Mohammadi E et al. (2021) 'Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications', Biomedicine and Pharmacotherapy, 139(), pp. -.
Vancouver	Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, et al.. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications. Biomedicine and Pharmacotherapy. 2021;139():-.
BibTex	@article{ author = {Mohammadi E and Shafiee F and Shahzamani K and Ranjbar MM and Alibakhshi A and Ahangarzadeh S and Beikmohammadi L and Shariati L and Hooshmandi S and Ataei B and Javanmard SH}, title = {Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications}, journal = {Biomedicine and Pharmacotherapy}, volume = {139}, number = {}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Mohammadi E AU - Shafiee F AU - Shahzamani K AU - Ranjbar MM AU - Alibakhshi A AU - Ahangarzadeh S AU - Beikmohammadi L AU - Shariati L AU - Hooshmandi S AU - Ataei B AU - Javanmard SH TI - Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications JO - Biomedicine and Pharmacotherapy VL - 139 IS - SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Abstract